glutathione and triple negative breast cancer Comprehensive single-cell metabolic profiling identifies targets to sensitize triple-negative to chemo-immunotherapy: Cell Reports Medicine Glutathione: Lights and Shadows in
Glutathione: Lights and Shadows in Cancer Patients PMC GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Full article: Glutathione and acid dual responsive nanomaterials loaded with methotrexate and magnolol for triple negative breast cancer treatment Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link
Pay in 4 interest-free payments of $5.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31




